Identification of imidazo[4,5-c]pyridin-2-one derivatives as novel Src family kinase inhibitors against glioblastoma
Glioblastoma multiforme (GBM) is the most common and malignant primary brain tumour in the central nervous system (CNS). As the ideal targets for GBM treatment, Src family kinases (SFKs) have attracted much attention. Herein, a new series of imidazo[4,5-c]pyridin-2-one derivatives were designed and...
Main Authors: | Lishun Zhang, Zichao Yang, Huiting Sang, Ying Jiang, Mingfeng Zhou, Chuan Huang, Chunhui Huang, Xiaoyun Wu, Tingting Zhang, Xingmei Zhang, Shanhe Wan, Jiajie Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14756366.2021.1948542 |
Similar Items
-
6-Bromo-2-(4-chlorophenyl)-3-[(1-octyl-1H-1,2,3-triazol-4-yl)methyl]-3H-imidazo[4,5-b]pyridine
by: Selma Bourichi, et al.
Published: (2019-01-01) -
Exploring Antimicrobial Features for New Imidazo[4,5-b]pyridine Derivatives Based on Experimental and Theoretical Study
by: Mohammed-yassin Hjouji, et al.
Published: (2023-04-01) -
Biological Activity of Amidino-Substituted Imidazo [4,5-<i>b</i>]pyridines
by: Ida Boček Pavlinac, et al.
Published: (2022-12-01) -
Synthesis and Antiproliferative Activity of 2,6-Disubstituted Imidazo[4,5-<i>b</i>]pyridines Prepared by Suzuki Cross Coupling
by: Ida Boček Pavlinac, et al.
Published: (2023-10-01) -
The (Patho)Biology of SRC Kinase in Platelets and Megakaryocytes
by: Lore De Kock, et al.
Published: (2020-11-01)